What's Happening?
NASA's Translational Research Institute for Space Health (TRISH) is inviting proposals to study venous thromboembolism (VTE) in space. VTE, a condition involving blood clots in veins, poses significant health risks during spaceflight. The mechanisms of
VTE in microgravity are not well understood, and current preventive measures are limited. TRISH aims to advance understanding of VTE pathophysiology in space and develop ground-based analogs to replicate these conditions. The initiative seeks innovative research to close knowledge gaps and support future space exploration missions. Proposals are open to U.S. institutions and companies, with a deadline of August 18, 2026.
Why It's Important?
Understanding VTE in space is crucial for the safety of astronauts on long-duration missions. Blood clots can lead to serious complications, such as pulmonary embolism, which could be life-threatening in space. By addressing this issue, NASA aims to enhance the health and safety protocols for astronauts, ensuring successful and safe space exploration. The research could also have implications for medical practices on Earth, particularly in understanding and treating VTE in various environments.
What's Next?
Selected research projects will receive funding of up to $500,000 and are expected to last up to 15 months. The outcomes of these studies could lead to the development of new medical protocols and technologies to prevent and treat VTE in space. This research will contribute to NASA's broader efforts to ensure the health of astronauts on missions to the Moon, Mars, and beyond.
